Patent Assignment
Reel/Frame 045363/0761
Merger
Recorded: 2018-03-27
Pages: 2
Assignor
ADMUNE THERAPEUTICS LLC
Executed: 2017-06-20
Assignee
NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.
181 MASSACHUSETTS AVENUE, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Property
(1)
Il-15 and Il-15RALPHA Heterodimer Dose Escalation Regimens for Treating Conditions
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 2, 2017
From: FELBER, BARBARA K.; PAVLAKIS, GEORGE N.
To: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 044019/0511 →
Assignment of Assignor's Interest
Nov 2, 2017
From: VOURNAKIS, JOHN N.; FINKIELSZTEIN, SERGIO
To: ADMUNE THERAPEUTICS LLC
Reel/Frame 044022/0056 →
Assignment of Assignor's Interest
Mar 29, 2018
From: NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC.
To: NOVARTIS AG
Reel/Frame 045386/0984 →